Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Half-year Report

12th Sep 2018 07:00

RNS Number : 4788A
Cambian Group PLC
12 September 2018
 

This announcement contains inside information 12 September 2018

Cambian Group plc

("Cambian" or "the Group" or "the Company")

 

Unaudited results for the six months ended 30 June 2018

Summary financials - continuing operations

2018 H1

2017 H1

 2017 FY

Revenue

£105.2m

£100.6m

£196.0m

Adjusted EBITDA 1

£11.8m

£8.4m

£18.7m

Adjusted EBITDA margin

11.2%

8.3%

9.5%

Operating profit before exceptional items 2

£4.0m

£0.3m

£2.4m

Operating profit/(loss)

£1.7m

£(1.2)m

£(8.8)m

Profit/(loss) before tax

£1.6m

£(1.2)m

£ (9.0)m

Net cash 3

£75.5m

£121.9m

£82.8m

Adjusted basic earnings per share 4

2.8p

1.4p

3.6p

Statutory basic earnings/(loss) per share - continuing

0.7p

(0.6)p

(4.3)p

1 Adjusted EBITDA is earnings before net finance costs, tax, depreciation, amortisation, profit or loss on disposal of assets, IPO share option charges and exceptional items (note 2).

2 Exceptional items are defined in the accounting policies (note 1).

3 Cash and cash equivalents net of obligations under finance leases, 2017 H1 comparative has been re-presented to align with this definition.

4 Adjusted basic earnings per share is defined as statutory basic earnings per share before amortisation of acquired intangible assets, IPO share option charges and exceptional items, net of the tax effect of these adjustments (note 7).

 

Highlights

Good underlying performance of the business in line with the Board's expectations.Revenue growth from operations of 7% to £105.2m (2017 H1: £98.2m excluding other income) driven by re-positioning to higher severity services resulting in an increase in average fees. Increase of 40% in adjusted EBITDA to £11.8m (2017 H1: £8.4m) reflects the growth in revenue from improved fees and a reduction in overheads following restructuring of the cost base.Adjusted EBITDA margin increased to 11.2% (2017 H1: 8.3%).Strong balance sheet with net cash of £75.5m (2017 H1: £121.9m) following the payment of the special dividend of £50.0m in September 2017 and a further special dividend of £15.0m in February 2018.Net cash from operating activities was an inflow of £11.5 million (2017 H1: £7.7 million inflow).Right-sizing of head office and central functions completed in 2018 Q1 with anticipated annualised savings of approximately £8.5m.Recommended Offer for Cambian Group plc by CareTech Holdings PLC announced on 16 August.

 

Saleem Asaria, Chief Executive Officer, commented:

 

"The Group is performing in line with the Board's expectations and we are very pleased with our first set of results as a pure children's specialist education and behavioural health services company. These results are in line with the medium-term strategy presented in January and further opportunity exists to improve occupancy and margins."

 

 

 

Enquiries:

 

 

Cambian Group plc +44 (0) 208 735 6150

CNC +44 (0) 203 219 8800

 

Saleem Asaria, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

Richard Campbell +44 (0) 777 578 4933

Katherine Fennell +44 (0) 797 182 8445

 

 

A results teleconference will be held for analysts at 8.30am today. If you would like to attend, please confirm your attendance to [email protected].

The presentation to be given by management will be made available ahead of time at: http://www.cambiangroup.com/cambiangroup/investor/home.aspx 

Conference call dial-in details are available below.

 

Conference Call:

Conference ID 57326508#

UK FreeCall Dial-In 0800 358 9473

Std International Dial-In +44 (0) 333 300 0804

Conference Call Replay (accessible for 90 days):

Conference ID 301243278#

UK FreeCall 0800 358 2049

Std International +44 (0) 333 300 0819

 

About Cambian:

Cambian Group is one of the UK's leading children's specialist education and behavioural health service providers. Founded in 2004, it has grown to become a significant partner to the UK public sector. The Group's services have a specific focus on children who present high severity needs with challenging behaviours and complex care requirements. Cambian employs over 4,500 people across a portfolio of approximately 220 residential facilities, specialist schools and fostering offices located in England and Wales.  

Chief Executive's review

Overview

The good underlying performance of the business in the first half of 2018 is in line with the Board's expectations and reflects the progress the Group has made to re-position itself towards higher severity services.

 

Revenue increased by 5% to £105.2 million (2017 H1: £100.6 million) primarily from the increase in fees from moving more of our portfolio to higher severity services. Revenue in 2017 H1 includes £2.4 million received from the Transitional Services Agreement ("TSA") which ended on 28 June 2017. Revenue, excluding income from the TSA, increased by 7%.

 

Adjusted EBITDA increased by 40% to £11.8 million (2017 H1: £8.4 million) with an adjusted EBITDA margin of 11.2%, representing a good performance during a period of transition. This reflects a growth in revenue, complemented by a reduction in overheads following a restructuring of the cost base.

 

Average occupancy levels decreased slightly during the period at 1,263 places (2017 FY: 1,286) predominantly as a result of the planned closure of one of the Specialist Education sites.

 

New admissions and the continued re-positioning to higher severity services helped deliver an improvement in the average daily fee for Residential Care and Specialist Education of 8% to £369 (2017 H1: £342).

 

The Group's closing capacity at 30 June 2018 was 1,617 places (2017 FY: 1,643 places) reflecting a net reduction of 26 places since the end of 2017. The reduction, predominantly within the Specialist Education division, relates to the closure of Southwick Park School in April 2018. This property was sold for £5.1 million in July, which was £1.3 million above its book value at 31 December 2017.

 

Closing occupancy was 1,266 places giving a stable closing utilisation of 78% (2017 FY: 77%).

 

Closing occupancy in the Fostering division increased 6% to 688 placements during the period (2017 FY: 649).

 

Focus on re-positioning of the Children's Service business

The Group's strategy has involved re-positioning more of its Residential Care and Specialist Education services and focusing its Fostering services entirely on higher acuity therapeutic fostering. The Group has made significant progress in this transition.

 

The Group's ongoing focus is to fill existing capacity, increase fee levels and reduce the cost base to increase margins. Good progress has been made in increasing average fee levels and average occupancy levels have remained stable.

 

Processes and systems

The Group has focussed on improving its processes to enable it to operate more efficiently with its existing systems and to support its continued strategy to re-position to higher severity services.

 

Quality and regulatory

The Group remains committed to providing the highest quality specialist education and behavioural health services to children. Its regulatory scores continued to be in line with sector averages with 79% of services rated Good or Outstanding with Ofsted or CQC as at 30 June 2018 (2017 FY: 80%).

 

The sector continues to see an increasingly stringent regulatory environment with an enhanced rigour of inspections. This is welcomed and we are well-positioned to benefit from this drive to improve the focus on our quality of care. Our aim is to achieve Good or Outstanding ratings in all of our facilities. In the short-term some fluctuation may be expected during the transition to higher severity services.

 

Dividend

The Board has decided not to announce an interim dividend in view of the Recommended Offer by CareTech Holdings PLC.

 

Outlook

Results for the first six months of the year are in line with the Board's expectations and on track for the full year outlook for 2018.

 

Recommended Offer

The Boards of CareTech Holdings PLC ("CareTech") and Cambian Group plc ("Cambian") announced on 16 August that they had reached agreement on the terms of a recommended acquisition of Cambian by CareTech, which is intended to be implemented by way of a scheme of arrangement of Cambian under Part 26 of the Companies Act, pursuant to which CareTech will acquire, at Completion, the entire issued and to be issued ordinary share capital of Cambian.

 

The scheme document and the CareTech prospectus are expected to be published during the week commencing 17 September 2018.

 

Saleem Asaria

Chief Executive Officer 

Finance review

Capacity and occupancy

Average occupancy decreased marginally during the period following the planned closure of one of the Specialist Education sites and the temporary closure of certain residential sites that have now reopened. Capacity utilisation at 30 June 2018 increased from year end to 78% (2017 FY: 77%).

 

Capacity and occupancy

2018 H1

2017 H11 

2017 FY

Average operational capacity

1,655

1,641

1,641

Average occupancy

1,263

1,292

1,286

Average utilisation

76%

79%

78%

Closing operational capacity

1,617

1,640

1,643

Closing occupancy

1,266

1,332

1,271

Closing utilisation

78%

81%

77%

Average fostering placements2

670

636

634

Fill rate3

1.40

1.43

1.41

1 Re-presented to reflect calculation based on average daily rather than monthly occupancy levels.

2 Fostering is excluded from the capacity and occupancy numbers and disclosed separately.

3 Ratio of foster placements to foster parents.

 

Fees

The average daily fee increased by 8% to £369 (2017 H1: £342) reflecting improved fee levels from higher severity services.

 

Fees

2018 H1

2017 H12

2017 FY

Average daily fee (excluding Fostering)1

£369

£342

£348

Fostering average daily fee1

£135

£131

£132

1 Implied daily fee from revenue (excluding other income for 2017 H1 and the impact of revenue phasing in Education to reflect performance obligations is removed) and average number of places or foster placements during the period.

2 Re-presented to reflect calculation based on average daily occupancy levels rather than monthly occupancy levels, and impact of revenue phasing in Education to reflect performance obligations is removed.

 

Revenue

The Group delivered underlying growth in revenue of 7% to £105.2 million (2017 H1: £98.2 million) reflecting the re-positioning to higher severity services and increases in fees. The total growth in revenue of 5% from 2017 H1 includes £2.4 million received from the TSA, which ended on 28 June 2017.

 

Revenue

2018 H1

2017 H1

2017 FY

Revenue

£105.2m

£100.6m

£196.0m

Fostering Revenue1

£16.3m

£15.1m

£30.6m

1 Fostering revenue is included within revenue, and also disclosed separately.

 

Adjusted EBITDA

Adjusted EBITDA increased to £11.8 million (2017 H1: £8.4 million) reflecting the growth in revenue and a reduction in overheads.

 

Adjusted EBITDA

2018 H1

2017 H1

2017 FY

Adjusted EBITDA1

£11.8m

£8.4m

£18.7m

Adjusted EBITDA margin

11.2%

8.3%

9.5%

1 Adjusted EBITDA is earnings before net finance costs, tax, depreciation, amortisation, profit or loss on disposal of assets, IPO share option charges and exceptional items (Note 2).

 

Operating profit

Operating profit before exceptional items was £4.0 million (2017 H1: £0.3 million). After exceptional costs of £2.3 million (2017 H1: £1.5 million), which relate mainly to one off IT system costs, non-contingent transaction fees incurred in relation to the potential sale of the Group, and restructuring following the closure of one site, the operating profit was £1.7 million in 2018 H1 (2017 H1: £1.2m loss).

 

 

Finance charges

Finance costs have remained constant at £0.2 million (2017 H1: £0.2 million) and relate predominantly to commitment fees incurred on the £30 million revolving credit facility which was taken out in May 2017.

 

Tax

The Group's tax charge was £0.4 million (2017 H1: £0.2 million credit) which represents an effective tax rate of 22.0% (2017 H1: 17.5%). The difference between the current statutory rate of 19.0% and the effective tax rate is principally due to non-deductible expenditure.

 

Earnings per share

Adjusted basic earnings per share was 2.8 pence (2017 H1: 1.4 pence) and statutory basic earnings per share was 0.7 pence (2017 H1: 0.6 pence loss), reflecting the improved profit after tax.

 

Capital expenditure

£4.7 million (2017 H1: £2.2 million) of capital expenditure was incurred, of which £1.2 million (2017 H1: £0.5 million) was spent on the development of new capacity, and £3.5 million (2017 H1: £1.7 million) was spent on the improvements to existing sites, including re-positioning of services and the conversion of leasehold properties to freehold.

 

Cash flow

Net cash from operating activities was an inflow of £11.5 million (2017 H1: £7.7 million inflow). Net cash of £75.5 million (2017 H1: £121.9 million net cash) reflects the return of capital to shareholders of £50.0 million on 15 September 2017 and of £15.0m on 28 February 2018. Operating cash conversion was 119% and represents cash flow from operating activities adjusted for cash outflow from exceptional items, divided by adjusted EBITDA.

 

Return of capital

On 18 February 2018, a special dividend of £15.0 million (8.2 pence per share) was paid to shareholders.

 

Sleep-ins

Although there were no significant developments between 1 January 2018 and 30 June 2018, on 13 July 2018, the Court of Appeal published a judgement which overturned earlier decisions. The Court of Appeal has confirmed that social care staff must be paid the National Minimum Wage ('NMW') only for those parts of sleep-in shifts when the member of staff is awake for the purposes of working.

 

On 8 August the trade union organisation, UNISON, supported an application for leave to appeal this decision to the Supreme Court. That application is currently being considered and it is believed that a decision on the application is likely to be made during the second half of 2018. If leave to appeal is granted, the Supreme Court hearing is unlikely to be held before late 2019. On the basis of this uncertainty, Cambian has maintained its historical and current provisions. 

 

Principal risks and uncertainties

The principal risks and uncertainties facing the business are considered to be as follows:

 

Risk

Description & Impact

Quality of Service

Failure to provide a high quality and consistent level of care for the children and young people placed under our charge.

Regulatory Breach

Loss or suspension of operating licences due to a major statutory, regulatory or contractual compliance breach.

Service Innovation

Insufficient innovation in our business model, service offerings or model of care reduces our competitiveness in the market.

Incident Response

Inability to effectively react and respond to a major incident or systematic incidents in a timely and controlled manner.

Relationships

Failure to create and maintain strong relationships with commissioners to ensure referrals and conversions at appropriate prices.

Systems & Processes

Immaturity of financial and operational systems and processes prevents effective business operations and sustainable future growth.

Attraction & Retention

Failure to attract and maintain an effective, high quality resource and talent base may prevent the delivery of a high quality service to the service users. Uncertainty regarding outcome of takeover may unsettle staff and increase turnover rates

Strategy & Performance

Failure to develop, execute and operate a strategic plan that ensures continued viable growth.

Integration

Failure to realise the benefits and synergies of effectively integrating new sites and acquisitions.

Business Change

Failure to effectively deliver key business change programmes to improve controls and processes.

Government Action

Failure to anticipate or respond to changes in government policy or regulation.

National Living Wage

Additional costs of national living wage on "sleep-ins" could be material.

 

Further details on the principal risks and uncertainties can be found in the Group's Annual Report and Accounts 2017.

Responsibility statement

We confirm to the best of our knowledge that this unaudited consolidated interim financial information has been prepared in accordance with IAS 34 as adopted by the European Union and that the interim management report includes a fair review of the information required by DTR 4.2.7R and DTR 4.2.8R, namely:

an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year; andmaterial related-party transactions in the first six months and any material changes in the related-party transactions described in the last Annual Report and Accounts.

 

 

By order of the Board

 

 

Saleem Asaria

Anoop Kang

Chief Executive Officer

Chief Financial Officer

 

Cautionary Statement

Certain statements in this half yearly statement are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise. 

 

Condensed Consolidated Statement of Comprehensive Income

 

Notes

Six months

30 June

2018

£'000

(Unaudited)

 

 

Six months

30 June

2017

£'000

(Unaudited)

 

 

Year ended

31 December 2017

£'000

(Audited)

 

 

 

 

 

 

 

Revenue

3

105,186

 

100,566

 

195,952

Cost of sales

 

(83,114)

 

(78,953)

 

(158,513)

Gross profit

 

22,072

 

21,613

 

37,439

Administrative expenses

 

(20,348)

 

(22,765)

 

(46,253)

Operating profit/(loss)

 

1,724

 

(1,152)

 

(8,814)

 

 

 

 

 

 

 

Operating profit before exceptional items

 

4,007

 

307

 

2,350

Exceptional items within administrative expenses

4

(2,283)

 

(1,459)

 

(11,164)

Operating profit/(loss)

 

1,724

 

(1,152)

 

(8,814)

 

 

 

 

 

 

 

 

Finance income

 

85

 

106

 

218

Finance costs

 

(211)

 

(190)

 

(399)

Profit/(loss) before tax

 

1,598

 

(1,236)

 

(8,995)

 

Tax

5

(352)

 

183

 

1,198

Profit/(loss) for the period from continuing operations

 

1,246

 

(1,053)

 

(7,797)

 

 

 

 

 

 

 

Discontinued operations

 

 

 

 

 

 

Profit/(loss) for the period from discontinued operations

6

750

 

(3,985)

 

(3,566)

Profit/(loss) for the period

 

1,996

 

(5,038)

 

(11,363)

 

 

 

 

 

 

 

Total comprehensive income/(loss) for the period1

 

1,996

 

(5,038)

 

 

(11,363)

 

 

 

 

 

 

 

Earnings/(loss) per share

 

 

 

 

 

 

Basic (pence per share)

7

0.7

 

(0.6)

 

(4.3)

Diluted (pence per share)

7

0.7

 

(0.6)

 

(4.3)

 

1 Wholly attributable to owners of the ultimate holding company

 

Condensed Consolidated Statement of Financial Position

 

Notes

30 June

2018£'000

(Unaudited)

 

 

30 June2017£'000

(Unaudited)

 

 

31 December 2017£'000

(Audited)

 

 

 

 

 

 

 

Goodwill

 

75,783

 

75,783

 

75,783

Other intangible assets

 

39,555

 

43,808

 

41,678

Property, plant and equipment

 

169,707

 

174,070

 

170,703

 

 

 

 

 

 

 

Non-current assets

 

285,045

 

293,656

 

288,164

 

 

 

 

 

 

 

Trade and other receivables

 

17,737

 

30,525

 

22,609

Cash and cash equivalents

8

75,705

 

122,335

 

83,056

Current tax asset

 

-

 

3,410

 

-

Prepayments and accrued income

 

3,406

 

2,555

 

3,224

 

 

 

 

 

 

 

Current assets

 

96,848

 

158,825

 

108,889

 

 

 

 

 

 

 

Total assets

 

381,893

 

452,481

 

397,053

 

 

 

 

 

 

 

Trade and other payables

 

(31,993)

 

(28,315)

 

(22,208)

Provisions

 

(137)

 

(10,426)

 

(1,603)

Deferred revenue

 

(16,858)

 

(19,817)

 

(28,491)

Obligations under finance leases

 

(168)

 

(225)

 

(132)

Borrowings

 

(87)

 

-

 

-

Current tax liabilities

 

(1,822)

 

-

 

(1,729)

 

 

 

 

 

 

 

Current liabilities

 

(51,065)

 

(58,783)

 

(54,163)

 

 

 

 

 

 

 

Net current assets

 

45,783

 

100,042

 

54,726

 

 

 

 

 

 

 

Obligations under finance leases

 

(57)

 

(229)

 

(144)

Provisions

 

(11,035)

 

-

 

(9,777)

Deferred tax liabilities

 

(21,211)

 

(26,559)

 

(21,540)

 

 

 

 

 

 

 

Non-current liabilities

 

(32,303)

 

(26,788)

 

(31,461)

 

 

 

 

 

 

 

Total liabilities

 

(83,368)

 

(85,571)

 

(85,624)

 

 

 

 

 

 

 

Net assets

 

298,525

 

366,910

 

311,429

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

Share capital

 

1,842

 

1,842

 

1,842

Share premium

 

20,499

 

20,499

 

20,499

Merger reserve

 

391,459

 

322,559

 

391,459

Other reserves

 

 (137,981)

 

(139,024)

 

(138,494)

Retained earnings

 

22,706

 

161,034

 

36,123

 

 

 

 

 

 

 

 

Total equity

 

298,525

 

366,910

 

311,429

Condensed consolidated statement of changes in equity

 

 

Share capital

£'000

Share premium

£'000

Merger reserve

£'000

Other reserves

£'000

Retained earnings

£'000

Total

£'000

 

 

 

 

 

 

 

Balance at 1 January 2017

1,842

20,499

391,459

(139,665)

97,172

371,307

Total comprehensive loss for the period

-

-

-

-

(5,038)

(5,038)

Transfer from merger reserve

-

-

(68,900)

-

68,900

-

Credit to equity for equity settled share-based payments

-

-

-

641

-

641

Balance at 30 June 2017

1,842

20,499

322,559

(139,024)

161,034

366,910

Total comprehensive loss for the period

-

-

-

-

(6,325)

(6,325)

Transfer from merger reserve

 

 

68,900

-

(68,900)

-

Dividends

-

-

-

-

(49,686)

(49,686)

Credit to equity for equity-settled share-based payments

-

-

 

530

-

530

Balance at 31 December 2017

1,842

20,499

391,459

(138,494)

36,123

311,429

Total comprehensive income for the period

-

-

-

-

1,996

1,996

Dividends

-

-

-

-

(15,413)

(15,413)

Credit to equity for equity-settled share-based payments

-

-

-

513

-

513

Balance at 30 June 2018

1,842

20,499

391,459

(137,981)

22,706

298,525

Condensed Consolidated Statement of Cash Flows

 

Notes

 Six months

30 June

2018

£'000

(Unaudited)

Six months

30 June

2017

£'000

(Unaudited)

Year ended

31 December 2017

£'000

(Audited)

 

 

 

 

 

 

 

 

 

 

Net cash inflow from operating activities

9

11,523

7,731

29,884

 

 

 

 

 

Investing activities

 

 

 

 

Proceeds on disposal of property, plant and equipment

 

347

150

1,081

Purchases of property, plant and equipment

 

(4,670)

(2,246)

(10,764)

Sale of Adult business - discontinued operations

 

-

-

(3,985)

 

 

 

 

 

Net cash used in investing activities

 

(4,323)

(2,096)

(13,668)

 

 

 

 

 

Financing activities

 

 

 

 

 

 

 

 

 

Dividends paid

 

(14,957)

-

(49,686)

Repayments of obligations under finance leases

 

(57)

(108)

(294)

 

 

 

 

 

Net cash used in financing activities

 

(15,014)

(108)

(49,980)

 

 

 

 

 

 

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

 

(7,814)

5,527

(33,764)

 

 

 

 

 

Net increase in cash held on behalf of clients

 

463

151

163

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

83,056

116,657

116,657

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

8

75,705

122,335

83,056

 

 

 

 

 

 

 

Notes to the condensed set of financial statements

1. Accounting policies

 

General information

Cambian Group plc. (the "Company") is a company incorporated in England and Wales under the Companies Act 2006 and its registered office is at 4th Floor, Waterfront Manbre Wharf, Manbre Road, Hammersmith, London W6 9RH. The Company is listed on the London Stock Exchange. The principal activity of the Company and its subsidiaries (collectively, the "Group") is the provision of high quality behavioural health services to children.

 

Basis of preparation

The financial information contained in this Half-Yearly Financial Report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The results for the year ended 31 December 2017 are an abridged version of the full accounts for that year, which received an unqualified report from the auditor, did not contain a statement under section 498(2) or (3) of the Companies Act 2006 or include a reference to any matter to which the auditor drew attention by way of emphasis without qualifying the auditor's report, and have been filed with the Registrar of Companies. The annual financial statements of the Company are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this Half-Yearly Financial Report has been prepared in accordance with IAS 34 Interim Financial Reporting, as adopted by the European Union. The same accounting policies, presentation and methods of computation are followed in the condensed set of financial statements as applied in the latest audited annual financial statements except as noted below.

 

Change in accounting policies - IFRS 9

The Company has adopted IFRS 9 Financial Instruments from 1 January 2018. There has been no change in presentation as a result of this as the Company has no complex financial instruments. The impact on impairment of financial assets has been considered as IFRS 9 mandates the use of an expected credit loss model to calculate impairment losses rather than an incurred loss model. The new impairment model applies to the Company's financial assets, and no changes to the impairment provisions were made on transition to IFRS 9 as the majority of trade receivables are principally with local authorities controlled by the UK government. Therefore the inclusion of specific expected credit loss considerations did not have a material impact.

 

Change in accounting policies - IFRS 15

The Company has adopted IFRS 15 Revenue from Contracts with Customers from 1 January 2018. The primary impact of application is the revision of accounting policies to reflect the five-step approach to revenue recognition required by IFRS 15. This has not resulted in any adjustments as under IAS18 revenue was recognised over the period in which a service was provided, and under IFRS 15 revenue is recognised over time, as performance obligations are satisfied.

 

Exceptional items

Exceptional items reflect items of non-recurring expenditure that have been disclosed separately due to their size or incidence in order to obtain clear and consistent presentation of the Group's performance (see note 4).

 

Going concern

The directors have, at the time of approving the financial statements, a reasonable expectation that the Group have adequate resources to continue in operational existence for the foreseeable future. Accordingly, they have adopted the going concern basis of accounting in preparing the financial statements. The directors have considered the Group's forecasts and projections, taking account of reasonably possible changes in trading performance, and are satisfied that the Group should be able to operate within the level of its current facilities. Consideration has also been given to the recommended offer on 16 August 2018 (see note 12)

 

Critical accounting judgements and key sources of estimation uncertainty

 

The key assumptions concerning the future, and other key sources of estimation uncertainty at the balance sheet date, that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next financial year are consistent with those set out in the 2017 Annual Report and Accounts. These include the carrying value of goodwill and trade receivables, the judgements in connection with the "sleep-ins", and an onerous contract.

 

Sleep-ins

 

A sleep-in refers to a type of work shift, commonly used in the care industry, where employees "sleep-in" and are paid an allowance for doing so. HMRC's view is that hours spent by employees performing sleep-in count as "working time" and therefore should be included when calculating whether or not someone has been paid in accordance with the National Minimum Wage Regulations 2015. In November 2017, HMRC reiterated its position and invited companies to join the Social Care Compliance Scheme, a self-reporting scheme aimed at concluding historic payments regarding sleep-ins. Cambian have opted into the scheme. Whilst a number of other care service providers have challenged HMRC's original view, if it is ultimately individually determined that Cambian had to pay each individual engaged in a sleep-in an amount by reference to the National Living Wage, the additional cost could be material. The directors have used their judgement to provide for this matter. The Group has provided £10.6 million against the historic treatment of sleep-ins as at 30 June 2017. 

 

 

2. Segmental analysis

 

Products and services from which reportable segments derive their revenues

Following the sale of the Adult Services business in December 2016, the directors have determined there is one remaining operating segment.

 

The Group assesses performance using adjusted EBITDA as its primary measure. This reflects the underlying performance of the business and provides an additional useful comparison of how the business is managed and measured on a day to day basis. Our KPIs are aligned to our strategy and together are used to measure the performance of our business and form the basis of the performance measures for remuneration.

 

The following is an analysis of the Group's revenue and results based on continuing operations.

 

 

Six months

30 June

2018

£'000

(unaudited)

 

Six months 30 June

2017

£'000

(unaudited)

Year ended 31 December

2017

£'000

(audited)

 

 

 

 

Revenue

105,186

100,566

195,952

 

 

 

 

 

 

 

 

Adjusted EBITDA1

11,781

8,404

18,687

Depreciation

(5,352)

(5,214)

(11,124)

Amortisation

(2,123)

(2,126)

(4,250)

Profit on disposal of property, plant and equipment

11

5

137

IPO share option charge2 

(310)

(762)

(1,100)

 

 

 

 

Operating profit before exceptional items

4,007

307

2,349

 

 

 

 

Exceptional items

(2,283)

(1,459)

(11,163)

 

 

 

 

Operating profit/(loss)

1,724

(1,152)

(8,814)

 

 

 

 

Net financing costs

(126)

(84)

(181)

 

 

 

 

Profit/(loss) before tax

1,598

(1,236)

(8,995)

 

 

 

 

Tax

(352)

183

1,198

 

 

 

 

Profit/(loss) after tax

1,246

(1,053)

(7,797)

 

 

 

 

1 Adjusted EBITDA is earnings before net finance costs, tax, depreciation, amortisation, profit or loss on disposal of assets, IPO share option charges and exceptional items (Note 4).

2 IPO share option charges arise on Continuation Option Plan shares awarded as part of the IPO, the impact of which is excluded from Adjusted EBITDA. Charges on future share based awards are included within Adjusted EBITDA.

 

3. Revenue

 

 

 

Six months

30 June

2018

£'000

(unaudited)

Six months

30 June

2017

£'000

(unaudited)

Year ended

31 December

2017

£'000

(audited)

 

 

 

 

Revenue from operations

105,174

98,145

195,952

Other income - rental

12

-

-

Other income -Transitional Services Agreement

-

2,421

-

 

 

 

 

Revenue

105,186

100,566

195,952

 

 

 

 

 

Revenue from operations is derived from the provision of specialist educational and behavioural health services for children in the UK. Other income in 2018 is derived from the letting of one of the Group's surplus properties to a third party. Other income in 2017 is derived from the Transitional Services Agreement to provide services relating to IT, finance, procurement and estates to the purchasers of the Adult Services business.

 

4. Exceptional items

 

The following table provides a breakdown of exceptional items:

 

 

Six months

30 June

2018

£'000

(unaudited)

Six months

30 June

2017

£'000

(unaudited)

Year ended

31 December

2017

£'000

(audited)

 

 

 

 

IT System costs

1,169

-

642

Transaction fees

634

-

-

Restructuring and reorganisation costs

Costs associated with the disposal of the Adult Services Business

480

-

-

1,459

888

1,245

Impairment of property, plant and equipment

-

-

5,177

Sleep-ins

-

-

3,460

Reversal of prior period exceptional provision

-

-

(248)

 

 

 

 

Exceptional items before tax

2,283

1,459

11,164

 

 

 

 

 

IT System costs relate predominantly to professional fees incurred in connection with a significant project on process simplification and system costs, following the sale of the Adult Services business. Transaction fees relate to non-contingent costs incurred in relation to the potential sale of the Group. Restructuring and reorganisation costs relate predominantly to costs incurred in the closure of one of its sites.

 

5. Tax

 

The tax charge in the statement of comprehensive income for the six months ended 30 June 2018 is calculated at a rate of 22.0% (H1 2017: 17.5%), which represents the best estimate of the annual effective tax rate expected for the full year applied to taxable profits for the six month period.

 

6. Discontinued operations

 

On 5 December 2016, the Group entered into a sale agreement to dispose of Cambian Healthcare Limited and its subsidiaries, Care Aspirations Developments Limited and its subsidiaries, and Cambian Care Services, ("the Adult Services business"), which carried out all of the Group's Adult Services operations. The disposal was completed on 28 December 2016, on which date control of the Adult Services business passed to the acquirer, Cygnet Health Care Limited ("Cygnet").

 

A profit of £144.3 million arose on the disposal of the Adult Services business, being the difference between the proceeds of disposal and the carrying amount of the subsidiaries' net assets sold. Under the terms of the Share Purchase Agreement, Cambian delivered a Closing Summary Statement on 24 April 2017 to Cygnet. On 15 September 2017 following formal negotiations between Cambian and Cygnet the purchase price decreased by £4.0 million to £379.0 million.

 

During 2016, as part of the transaction, it was identified that Cambian was a party to an exclusive supply agreement in respect of pharmaceutical supplies at its sites. This contract did not automatically transfer with the adult services business. The supplier indicated that in its view the sale is in breach of the agreement and is seeking either a novation of the agreement or compensation. Litigation has been formerly threatened but not yet commenced, and the directors have used their judgement to provide for this. In 2018, the directors obtained specialist legal advice on the matter and following this, the provision for this onerous contract has been reduced by £0.8 million.

 

The following table provides a breakdown of discontinued operations:

 

 

Six months

30 June

2018

£'000

(unaudited)

Six months

30 June

2017

£'000

(unaudited)

Year ended

31 December 2017

£'000

(audited)

 

 

 

 

 

 

 

 

Purchase price adjustment

-

(3,985)

(4,015)

Directly attributable costs

-

-

449

 

 

 

 

 

 

(3,985)

(3,566)

Onerous contract

750

-

-

 

 

 

 

Profit/(loss) after tax for discontinued operations

750

(3,985)

(3,566)

 

 

 

 

 

 

 

 

 

  

7. Earnings per share

 

The earnings/(loss) and weighted average number of ordinary shares used in the calculation of basic and diluted earnings per share are as follows:

 

 

 

Six months

30 June

2018

£'000

(unaudited)

Six months

30 June

2017

£'000 (unaudited)

Year ended

31 December 2017

£'000

(audited)

 

 

 

 

 

Profit/(loss) after tax for continuing operations

 

1,246

(1,053)

(7,797)

Profit/(loss) after tax for discontinued operations

 

750

(3,985)

(3,566)

 

 

 

 

 

Total profit/(loss) after tax for the period

 

1,996

(5,038)

(11,363)

 

 

 

 

 

 

 

 

 

 

 

 

 

Six months

30 June

2018

Number (unaudited)

Six months

30 June

2017

Number

(unaudited)

Year ended

31 December 2017

Number

(audited)

 

 

 

 

 

Weighted average ordinary shares used in the calculation of basic earnings per share

 

182,472,675

182,472,675

182,402,674

Weighted average ordinary shares used in the calculation of diluted earnings per share

 

184,198,746

182,472,675

182,402,674

Weighted average of share options under the Continuation Option Plans

 

1,795,916

2,473,810

1,796,072

 

In prior periods, the weighted average of share options under the Continuation Option Plans has been excluded from the calculation of diluted earnings per share as they were anti-dilutive for the periods presented but could dilute earnings per share in the future.

 

Adjusted basic earnings per share reconciles to statutory basic earnings per share as follows:

 

 

 

Six months

30 June

2018

Pence

(unaudited)

Six months

30 June

2017

Pence (unaudited)

Year ended

31 December 2017

Pence

(audited)

 

 

 

 

 

Adjusted diluted earnings per share

 

2.7

1.4

3.6

Effect of dilution

 

0.1

-

-

 

 

 

 

 

Adjusted basic earnings per share

 

2.8

1.4

3.6

 

 

 

 

 

Adjusted basic earnings per share

 

2.8

1.4

3.6

Amortisation of acquired intangibles

 

(0.9)

(0.9)

(1.9)

IPO share option charges

 

(0.1)

 (0.3)

 (0.4)

Exceptional items

 

(1.1)

(0.8)

(5.6)

 

 

 

 

 

Basic and diluted profit/(loss) per share

 

0.7

(0.6)

(4.3)

 

 

 

 

 

 

 

8. Cash and cash equivalents

 

 

 

Six months

30 June

2018

£'000

(unaudited)

Six months

30 June

2017

£'000 (unaudited)

Year ended

31 December 2017

£'000

(audited)

 

 

 

 

 

Cash and bank balances

 

74,276

121,398

82,102

Cash held on behalf of clients

 

1,429

937

954

 

 

 

 

 

Cash and cash equivalents

 

75,705

122,335

83,056

 

 

 

 

 

 

Cash and cash equivalents include cash held on behalf of clients, which is not available for use by the Group. All interest earned on these funds is returned back to the client and is not included in the Group's statement of comprehensive income. An equivalent liability of £1.4 million (30 June 2017: £0.9 million and 31 December 2017: £1.0 million) exists for this amount.

 

9. Notes to the cash flow statement

 

 

Six months 30 June

2018

£'000

(unaudited)

Six months 30 June

2017

£'000

(unaudited)

Year ended 31 December 2017

£'000

(audited)

 

 

 

 

Profit/(loss) from continuing operations

1,598

(1,236)

(8,995)

 

 

 

 

Adjustments for:

 

 

 

Finance income

(85)

(106)

(218)

Finance costs

211

190

399

Depreciation of property, plant and equipment

5,352

5,214

11,124

Amortisation of intangible assets

2,123

2,126

4,250

Profit on disposal of property, plant and equipment

(11)

(5)

(137)

Impairment on property, plant and equipment

-

-

5,177

Other non-cash items

515

640

1,341

 

 

 

 

Operating cash flows before movements in working capital

9,703

6,823

12,941

 

 

 

 

Decrease in receivables

4,688

11,374

19,729

Decrease in payables

(2,220)

(11,321)

(4,635)

 

 

 

 

Cash generated by operations

12,171

6,876

28,035

 

 

 

 

Income taxes (paid)/received

(588)

883

1,972

Interest paid

(60)

(28)

(123)

 

 

 

 

Net cash generated from operating activities

11,523

7,731

29,884

 

 

 

 

 

Other non-cash items relate to the charge to the income statement on the IPO share option plans shares under Continuation Option Plan 1 and Continuation Option Plan 2, Long Term Incentive Plans, and non-cash exceptional items.

 

 

10. Related party transactions

 

Balances and transactions between Group companies have been eliminated on consolidation and are not disclosed in this note. Other than remuneration of executive and non-executive directors and members of the senior executive team, there were no related party transactions except for expenses paid to GI Partners (being a shareholder with representation on the Board) of £26,000 (six months ended 30 June 2017: £12,000). This amount was outstanding as at 30 June 2018 and was paid on 31 July 2018.

 

All related party transactions are considered to be on an arm's length basis, and in the ordinary course of business.

 

In addition to these related party transactions, the Group uses the services of PHS Group Limited, a hygiene business chaired by Christopher Kemball, our Chairman. The total cost of these services amount to £36,000 (six months ended 30 June 2017: £32,000) and Mr Kemball took no part in the contract negotiations.

 

11. Dividends

 

 

Six months 30 June

2018

£'000

(unaudited)

Six months 30 June

2017

£'000

(unaudited)

Year ended 31 December 2017

£'000

(audited)

 

 

 

 

 

 

 

 

 

 

 

 

Amounts recognised as distributions to equity holders in the year

 

 

 

 

 

 

 

Special dividend of 27.1p per share

-

-

49,431

2017 interim dividend of 0.14p per share

-

-

255

Special dividend of 8.2p per share

14,957

-

-

2017 final dividend of 0.25p per share

456

-

-

 

 

 

 

 

 

 

 

Net cash generated from operating activities

15,413

-

49,686

 

 

 

 

 

12. Subsequent events

 

Sleep-ins

On 13 July 2018, the Court of Appeal overturned an Employment Tribunal decision made in 2016, which had ruled that social care staff should be paid the National Minimum Wage ('NMW') for sleep-in shifts. The Court of Appeal ruled that sleep-in shifts fall into an exception from the NMW as staff are only 'available for work', which means the NMW would only be payable when the person was awake and working and not while asleep.

 

On 8 August the trade union organisation, UNISON, appealed to the Supreme Court against this decision. This appeal is currently being considered and it is possible that the Court will agree to hear the appeal. This may take 8-12 weeks. It may take between 12 to 18 months before any further decision on this appeal is made. On the basis of this uncertainty Cambian has maintained its historical and current provisions.

 

Recommended offer

The Boards of CareTech Holdings PLC ("CareTech") and Cambian Group plc ("Cambian") announced on 16 August that they had reached agreement on the terms of a recommended acquisition of Cambian by CareTech, which is intended to be implemented by way of a scheme of arrangement of Cambian under Part 26 of the Companies Act, pursuant to which CareTech will acquire, at Completion, the entire issued and to be issued ordinary share capital of Cambian.

 

The scheme document and the CareTech prospectus are proposed to be published in due course.

 

 Independent review report to Cambian Group plc (the "Company")

 

We have been engaged by the company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2018 which comprises the statement of comprehensive income, the balance sheet, the statement of changes in equity, the cash flow statement and related notes 1 to 12. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

This report is made solely to the company in accordance with International Standard on Review Engagements (UK and Ireland) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Financial Reporting Council. Our work has been undertaken so that we might state to the company those matters we are required to state to it in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company, for our review work, for this report, or for the conclusions we have formed.

Directors' responsibilities

 

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

As disclosed in note 1, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" as adopted by the European Union.

 

Our responsibility

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

Scope of Review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Financial Reporting Council for use in the United Kingdom. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2018 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

Deloitte LLP

Statutory Auditor

London, United Kingdom

11 September 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
IR UARKRWNAKAAR

Related Shares:

Cambian Group
FTSE 100 Latest
Value8,850.63
Change-34.29